EVs Answer to the CAR-Tease: Targeted Exosomes to Speed Toward Next-Gen Immunotherapies
Chimeric antigen receptors (CARs) displayed on extracellular vesicles and/or exosomes (EV-CARs) could offer a cell-free, scalable alternative to CAR-T therapies, with fewer side effects such as cytokine release syndrome (CRS). ... More